NHLBI Phase IIB Bridge and Small Market Awards Applicant Orientation Webinar

The NHLBI Phase IIB Bridge Award (RFA-HL-23-009) and the NHLBI Phase IIB Small Market Award (RFA-HL-23-008) programs can provide up to $3 Million over three (3) years to continue the commercialization of novel products in the NHLBI mission space, specifically towards the completion of milestones necessary to achieve regulatory approval.

The National Center for Advancing Translational Sciences (NCATS) will consider co-funding awards in the small market program (RFA-HL-23-008) that address rare diseases and pediatric populations, particularly platforms that address multiple rare diseases. Applicants who believe their technologies are relevant to the small market opportunity are encouraged to read this opportunity for specific definitions and areas of interest.

Applications to both programs will be accepted starting on Sunday, January 28, with an application deadline of Wednesday, February 28; an informational Webinar will be held on Thursday, January 25 at 1:00 p.m. ET.  

For more information, please read NOT-HL-23-125: Notice of Pre-Application Webinar for NHLBI SBIR Phase IIB Small Market Awards and Bridge Awards (RFA-HL-23-008 and RFA-HL-23-009) (nih.gov).